Inventor
Fabrice Piu
Inventor
San Diego, CA, US
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07KPeptides7%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,123,285Auris formulations for treating OTIC diseases and conditions202111,123,286Auris formulations for treating otic diseases and conditions202111,034,961Treatment using truncated Trk B and Trk C antagonists202110,918,594Controlled-release CNS modulating compositions and methods for the treatment of otic disorders202110,821,185Triglyceride otic formulations and uses thereof202010,772,828Controlled release antimicrobial compositions and methods for the treatment of otic disorders202010,751,281Auris formulations for treating otic diseases and conditions202010,272,034Auris formulations for treating otic diseases and conditions201910,232,044Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders201910,092,580Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders201810,066,229Treatment using truncated Trk B and Trk C antagonists20189,867,778'Controlled release antimicrobial compositions and methods for the treatment of otic disorders'20189,808,460'Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders'20179,744,126'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20179,603,796'Controlled release antimicrobial compositions and methods for the treatment of otic disorders'20179,511,020'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20169,486,405'Methods for the treatment of pediatric otic disorders'20169,427,472'Controlled release compositions for modulating free-radical induced damage and methods of use thereof'20169,333,171'Controlled-release CNS modulating compositions and methods for the treatment of otic disorders'20169,233,068'Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders'20169,205,048'Controlled release antimicrobial compositions and methods for the treatment of otic disorders'20159,132,087'Auris formulations for treating otic diseases and conditions'20159,066,855'Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders'20158,852,626'Controlled-release CNS modulating compositions and methods for the treatment of otic disorders'20148,846,770'Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders'20148,828,980'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20148,822,548'Compounds with activity at estrogen receptors'20148,784,870'Controlled release compositions for modulating free-radical induced damage and methods of use thereof'20148,680,082'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20148,680,083'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20148,658,626'Controlled release corticosteroid compositions and methods for the treatment of otic disorders'20148,648,119'Controlled release immunomodulator compositions and methods for the treatment of otic disorders'20148,575,122'Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders'20138,496,957'Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders'20138,399,018'Controlled release ion channel modulator compositions and methods for the treatment of otic disorders'20138,349,353'Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders'20138,318,817'Controlled release antimicrobial compositions and methods for the treatment of otic disorders'20128,030,297'Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders'20117,825,265'Compounds with activity at estrogen receptors'20107,348,140'Clinical indications for genotyping polymorphic variants of G-protein coupled receptors'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2021Based in San Diego, CA, US· patent location history
2011–2021Patents assigned to OTONOMY INC (37)· patent assignee history
2011–2021Patents assigned to UNIV CALIFORNIA (31)· patent assignee history
2012–2018Patents assigned to PIU FABRICE (16)· patent assignee history
2012–2018Patents assigned to LEBEL CARL (15)· patent assignee history
2012–2018Patents assigned to LICHTER JAY (15)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OTONOMY INC | 37 | 2011–2021 |
| UNIV CALIFORNIA | 31 | 2011–2021 |
| PIU FABRICEself | 16 | 2012–2018 |
| LEBEL CARL | 15 | 2012–2018 |
| LICHTER JAY | 15 | 2012–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 40 | 2008–2021 |